CoChat

STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy

Open access
Wang-Bishop, Lihong, Kimmel, Blaise R., Ngwa, Verra M., Madden, Matthew Z., Baljon, Jessalyn J., Florian, David C., Hanna, Ann, Pastora, Lucinda E., Sheehy, Taylor L., Kwiatkowski, Alexander J., Wehbe, Mohamed, Wen, Xiaona, Becker, Kyle W., Garland, Kyle M., Schulman, Jacob A., Shae, Daniel, Edwards, Deanna, Wolf, Melissa M., Delapp, Rossane, Christov, Plamen P., Beckermann, Kathryn E., Balko, Justin M., Rathmell, W. Kimryn, Rathmell, Jeffrey C., Chen, Jin, Wilson, John T. · 2023 · Science Immunology
Cited by 126

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

The tumor-associated vasculature imposes major structural and biochemical barriers to the infiltration of effector T cells and effective tumor control. Correlations between stimulator of interferon genes (STING) pathway activation and spontaneous T cell infiltration in human cancers led us to evaluate the effect of STING-activating nanoparticles (STANs), which are a polymersome-based platform for the delivery of a cyclic dinucleotide STING agonist, on the tumor vasculature and attendant effects on T cell infiltration and antitumor function. In multiple mouse tumor models, intravenous administration of STANs promoted vascular normalization, evidenced by improved vascular integrity, reduced tumor hypoxia, and increased endothelial cell expression of T cell adhesion molecules. STAN-mediated vascular reprogramming enhanced the infiltration, proliferation, and function of antitumor T cells and potentiated the response to immune checkpoint inhibitors and adoptive T cell therapy. We present STANs as a multimodal platform that activates and normalizes the tumor microenvironment to enhance T cell infiltration and function and augments responses to immunotherapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/sciimmunol.add1153

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

See all 126

Metadata

Authors
Wang-Bishop, L., Kimmel, B. R., Ngwa, V. M., Madden, M. Z., Baljon, J. J., Florian, D. C., Hanna, A., Pastora, L. E., Sheehy, T. L., Kwiatkowski, A. J., Wehbe, M., Wen, X., Becker, K. W., Garland, K. M., Schulman, J. A., Shae, D., Edwards, D., Wolf, M. M., Delapp, R., Christov, P. P., Beckermann, K. E., Balko, J. M., Rathmell, W. K., Rathmell, J. C., Chen, J., & Wilson, J. T.
Venue
Science Immunology
Published
2023-05-26
Volume
8
Issue
83
Pages
eadd1153-eadd1153
ISSN
2470-9468 (ISSN-L)
OpenAlex
W4372260796
Cited by
126
References
22
FWCI
13.04
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy. https://app.cochat.ai/papers/10.1126/sciimmunol.add1153
The paper
Wang-Bishop, L., Kimmel, B. R., Ngwa, V. M., Madden, M. Z., Baljon, J. J., Florian, D. C., Hanna, A., Pastora, L. E., Sheehy, T. L., Kwiatkowski, A. J., Wehbe, M., Wen, X., Becker, K. W., Garland, K. M., Schulman, J. A., Shae, D., Edwards, D., Wolf, M. M., Delapp, R., . . . Wilson, J. T. (2023). STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy. Science Immunology. https://doi.org/10.1126/sciimmunol.add1153

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.